Foundayo's First Month: A Solid Start in Obesity Meds

Eli Lillys new weight-loss pill, Foundayo, has made a promising start with over seven thousand prescriptions in its first month. However, it still trails behind Novo Nordisks Wegovy, which launched earlier. Foundayos success hinges on its potential to attract more patients and ease pricing pressures. With over eight thousand prescribers and twenty thousand treated patients, Foundayo is poised to make waves in the obesity medication market. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ce32907dceb690fd